VORTIOXETINE

02 January 2024
Volume 6 · Issue 1

Abstract

In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of posts on X. This month she is talking about #vortioxetine

Dr Sharon Rees @reesprescribe

Day 1: #vortioxetine is a unique antidepressant, discovered from exploring bis-aryl-sulfanyl amine compounds. It is categorised as a ‘serotonergic’ drug, acting both as an SSRI & as a serotonin receptor modulator. Approved for adults in the USA in 2013 & in Europe 2014

Dr Sharon Rees @reesprescribe

Day 2: Indication for #vortioxetine is major depressive disorder. Used when at least 2 other anti-depressants have not worked. Oral delivery 10mg od (5mg if >65) titrated to 20mg according to response (caution elderly >10mg). Continue minimum 6 months after symptoms resolve

Dr Sharon Rees @reesprescribe

Day 3: High but slow oral absorption, highly plasma protein bound & high Vd. Liver metabolism major via CYP2D6, minor 3A4/5 & 2C9. No active metabolites. 2/3 excretion urine, 1/3 faeces. T½ 66 hrs with around 2 weeks to steady state. No dose adjustment for renal/hepatic impairment, but this may be necessary for poor CYP2D6 metabolisers

Dr Sharon Rees @reesprescribe

Day 4: #vortioxetine has high affinity for the serotonin (5-HT) transporter & increases serotonin levels. It also acts as a 5-HT3 & 5-HT7 receptor antagonist & a 5-HT1A agonist. Further, multiple neural pathways may be modulated, such as NE, dopamine, ACh, histamine, as well as modulation GABA & glutamate, but much remains poorly understood

Dr Sharon Rees @reesprescribe

Day 5: Common adverse drug effects #vortioxetine: dizziness, nausea (taking with food might help), vomiting, GI disturbance, abnormal dreams, pruritus. Associated with a low risk of sexual dysfunction, but this may be more likely with higher doses. Weight gain/appetite changes are not stated as an ADE unlike common antidepressants e.g SSRIs & mirtazapine

Dr Sharon Rees @reesprescribe

Day 6: DDIs #vortioxetine. All drugs which can increase risk of bleeding eg NSAIDs. All other serotonergic drugs, including St John’s wort. CYP2D6 inhibitors e.g quinidine. All drugs which lower seizure threshold e.g other anti-depressants & neuroleptics

Dr Sharon Rees @reesprescribe

Day 7: #vortioxetine is believed not to require managed withdrawal, as trials showed no difference to placebo for discontinuation symptoms (BNF & SPC)

Earn your CPD certificate

With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice, you can earn your 1-hour CPD certificate

In addition to the posts, read the BNF section on depression, as well as the monograph on vortioxetine. Another useful source is the Summary of Product Characteristics for vortioxetine (see links below). Once you have completed this, answer the 10 questions. Submit your answers to reesprescribe@gmail.com. If you answer at least eight out of 10 questions correctly, you will receive your CPD certificate via email.

Further reading on #vortioxetine

  • https://bnf.nice.org.uk/treatment-summaries/depression/
  • https://bnf.nice.org.uk/drugs/vortioxetine/
  • https://www.medicines.org.uk/emc/product/7121/smpc#gref
  • Vortioxetine is not licensed for use in children TRUE or FALSE?
  • Vortioxetine is mostly used first-line for moderate to severe depression TRUE or FALSE?
  • The long half-life means steady state will be achieved in the first few days TRUE or FALSE?
  • Which of the following is FALSE?
  • A. Vortioxetine has a high volume of distribution
  • B. Vortioxetine is not linked to metabolic disturbance
  • C. Vortioxetine has a good cardiovascular safety profile
  • D. Vortioxetine has a range of formulations
  • 5 Which of the following is TRUE?
  • A. Dose adjustment is needed for the elderly
  • B. Dose adjustment is needed for renal impairment
  • C. Dose adjustment is needed for hepatic impairment
  • D. Dose adjustment is needed for cardiac disease
  • 6 Which of the following is TRUE?
  • A. Vortioxetine is a traditional selective serotonin reuptake inhibitor (SSRI)
  • B. Vortioxetine acts primarily on dopamine receptors
  • C. Vortioxetine has a multimodal mechanism of action
  • D. Vortioxetine’s main action is as a serotonin agonist
  • 7 Sexual dysfunction is a ‘common’ side-effect TRUE or FALSE?
  • 8 Vortioxetine is linked to severe withdrawal reactions TRUE or FALSE?
  • 9 Vortioxetine should not be used with other serotonergic drugs TRUE or FALSE?
  • 10 Vortioxetine is not linked to weight gain TRUE or FALSE?